Metabet Sr

Metformin, the active ingredient in Metabet Sr, is a Biguanide presented as an oral tablet for oral use. It lowers blood glucose levels and is used to manage type 2 diabetes mellitus in adult patients. Metformin works by reducing hepatic glucose production, decreasing intestinal absorption of glucose, and improving peripheral insulin sensitivity, making it a cornerstone therapy for chronic hyperglycemia.

GNH USA supplies Metabet Sr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution for regulated medicines.

Metabet Sr (metformin) is indicated for conditions within the type 2 diabetes mellitus therapeutic pathway.

- Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose levels.

Metabet Sr may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools, often transient. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Loss of appetite: reduced desire to eat.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic disturbance. - Severe hypoglycemia: usually when combined with insulin or secretagogues. - Vitamin B12 deficiency: may develop with long‑term use. - Skin rash: hypersensitivity reaction. - Hepatic dysfunction: abnormal liver enzymes in rare cases.

When prescribing Metabet Sr, clinicians should observe several precautionary measures to ensure patient safety.

- Renal function monitoring: assess creatinine clearance before initiation and periodically thereafter. - Hepatic function monitoring: evaluate liver enzymes in patients with known liver disease. - Lactic acidosis risk: avoid in patients with conditions predisposing to hypoxia or severe infection. - Pregnancy and lactation: weigh benefits against potential risks; generally avoided unless clearly needed. - Drug interaction review: check concomitant medications that may affect metformin levels. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Metabet Sr can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: increase risk of renal impairment and lactic acidosis. - Alcohol: potentiates lactic acidosis risk.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics: can affect renal clearance of metformin. - NSAIDs: may reduce renal perfusion and increase metformin exposure.